DK0470144T3 - D-Aspartic acid beta-hydroxamate for the treatment of viral infections and tumors - Google Patents

D-Aspartic acid beta-hydroxamate for the treatment of viral infections and tumors

Info

Publication number
DK0470144T3
DK0470144T3 DK90907159.9T DK90907159T DK0470144T3 DK 0470144 T3 DK0470144 T3 DK 0470144T3 DK 90907159 T DK90907159 T DK 90907159T DK 0470144 T3 DK0470144 T3 DK 0470144T3
Authority
DK
Denmark
Prior art keywords
hydroxamate
aspartic acid
tumors
treatment
viral infections
Prior art date
Application number
DK90907159.9T
Other languages
Danish (da)
Inventor
Jorge Vila
Nicole Thomasset
Sangsari Farid Hamedi
Jacques Grange
Original Assignee
Inst Nat Sant Et De La Rech M
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inst Nat Sant Et De La Rech M filed Critical Inst Nat Sant Et De La Rech M
Application granted granted Critical
Publication of DK0470144T3 publication Critical patent/DK0470144T3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/50—Hydrolases (3) acting on carbon-nitrogen bonds, other than peptide bonds (3.5), e.g. asparaginase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Beta-hydroxamate D-aspartic acid as a medicine, in particular for treating infections diseases caused by retroviruses, especially those that cause AIDS, as well as for treating tumours.
DK90907159.9T 1989-04-28 1990-04-27 D-Aspartic acid beta-hydroxamate for the treatment of viral infections and tumors DK0470144T3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8905744A FR2646348A1 (en) 1989-04-28 1989-04-28 D-ASPARTIC ACID-HYDROXAMATE AS A MEDICINAL PRODUCT

Publications (1)

Publication Number Publication Date
DK0470144T3 true DK0470144T3 (en) 1995-10-02

Family

ID=9381297

Family Applications (1)

Application Number Title Priority Date Filing Date
DK90907159.9T DK0470144T3 (en) 1989-04-28 1990-04-27 D-Aspartic acid beta-hydroxamate for the treatment of viral infections and tumors

Country Status (11)

Country Link
EP (1) EP0470144B1 (en)
JP (1) JPH04506796A (en)
AT (1) ATE121935T1 (en)
AU (1) AU660916B2 (en)
CA (1) CA2050936A1 (en)
DE (1) DE69019148T2 (en)
DK (1) DK0470144T3 (en)
ES (1) ES2072431T3 (en)
FR (1) FR2646348A1 (en)
OA (1) OA09519A (en)
WO (1) WO1990013291A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5705522A (en) * 1995-09-15 1998-01-06 Compagnie De Developpement Aguettant S.A. Compounds having anti-inflammatory and anti-viral activity, compositions of these, alone and in combination with reverse transcriptase inhibitors
ES2735991T3 (en) 2009-09-29 2019-12-23 Shiseido Co Ltd Antioxidant composition

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2600256B1 (en) * 1986-06-19 1988-09-16 Inst Nat Sante Rech Med DRUG AND DRUG COMPOSITION FOR THE TREATMENT OF TUMORS AND FOR THE TREATMENT OF VIRUS-INFECTIOUS DISEASES

Also Published As

Publication number Publication date
ATE121935T1 (en) 1995-05-15
WO1990013291A1 (en) 1990-11-15
EP0470144A1 (en) 1992-02-12
CA2050936A1 (en) 1990-10-29
DE69019148D1 (en) 1995-06-08
FR2646348A1 (en) 1990-11-02
AU5657590A (en) 1990-11-29
OA09519A (en) 1992-11-15
ES2072431T3 (en) 1995-07-16
AU660916B2 (en) 1995-07-13
EP0470144B1 (en) 1995-05-03
FR2646348B1 (en) 1994-04-22
DE69019148T2 (en) 1995-08-31
JPH04506796A (en) 1992-11-26

Similar Documents

Publication Publication Date Title
DE3876125T2 (en) TREATMENT OF HUMAN VIRAL INFECTION BY DOUBLE-STRAND RNA COMBINED WITH VIRAL INHIBITORS.
NO307968B1 (en) Pyrazolo- and pyrrolopyridines and pharmaceutical mixtures thereof
ATE148130T1 (en) TYPE IV DIPEPTIDYL AMINOOPEPTIDASE INHIBITORS
FI963070A0 (en) Klooripyrimidiinivälituotteita
DK480284D0 (en) TRUCKMARKED CONJUGATES OF METALLOTHIONEIN AND TARGETING, BIOLOGICAL ACTIVE MOLECULES
PT966447E (en) SMALL UTILIZATION MOLECULES IN THE TREATMENT OF INFLAMMATORY DISEASES
ES2051641A1 (en) Compounds and methods for inhibition of HIV and related viruses.
EA200300544A1 (en) EFFECTIVE ANTI-TUMOR MEDICINE
ES482097A1 (en) Novel acyl-derivatives of carnitine and process for their preparation
DK336688A (en) NUCLEOSIDES WITHOUT PROCEDURE FOR PREPARING THEREOF
ATE165345T1 (en) SULFONIC ACID DERIVATIVES FOR THE TREATMENT OF VIRUS DISEASES
SE9101815L (en) TREATMENT OF DISEASES ASSOCIATED WITH HIV INFECTIONS
ATE78696T1 (en) MEDICINAL PREPARATION FOR THE TREATMENT OF IMMUNE DEFICIENCY.
DE58909850D1 (en) MEDICINES FOR TREATING CANCER, AIDS AND VIRUS DISEASES
NO970573L (en) Yliden compounds and their preparation
DE3875016D1 (en) THERAPEUTIC FOR TREATING AIDS.
DK0470144T3 (en) D-Aspartic acid beta-hydroxamate for the treatment of viral infections and tumors
DK0656889T3 (en) 9-chloro-prostaglandin esters and amides and their use in the manufacture of drugs
DE3874606D1 (en) TREATING VIRAL INFECTION.
DK0817786T3 (en) Substituted tetronic acids useful for the treatment of HIV and other retroviruses
ATE69551T1 (en) COMPOSITION FOR TREATMENT OF MALIGNANT TUMORS, ESPECIALLY IN ANIMALS.
ATE212839T1 (en) HEMOREGULATORY COMPOUNDS
ATE95062T1 (en) COMPOSITION FOR THE TREATMENT OF CANCER CHARACTERIZED BY OVER-EXPRESSION OF THE C-FMSPROTO-ONCOGENE.
GEP19991605B (en) Inhibitor, Its Obtaining and Use
DE3884621D1 (en) COMPOSITION FOR THE TREATMENT OF CANCER, CHARACTERIZED BY OVEREXPRESSION OF THE C-FMS PROTO ONCOGEN.